EMD Serono and MyHealthTeams Launch Family Planning Resource Center to Provide Families Affected by Multiple Sclerosis with Information, Connection and Support
- Launch of new resource empowers prospective mothers with multiple sclerosis (MS) and their partners to have conversations about family planning
ROCKLAND, Mass., — January 09, 2020 — Today, EMD Serono announced the launch of the Family Planning Resource Center to support prospective mothers who are living with multiple sclerosis (MS) and their loved ones with family planning information and resources before, during and after pregnancy that is intended to supplement a patient’s relationship with her healthcare provider.
“Being proactive and planning ahead is so important for women living with MS and thinking about having a baby,” said Terrie Livingston, Head of Patient and Payor Solutions at EMD Serono. “Making it easy to find reliable, actionable information that a patient can use in conversation with her doctor is critical to helping people make the decisions that are right – for them, their baby and their family.”
Featured articles within the Family Planning Resource Center include:
- MS & Pregnancy: Questions to ask your doctor
- Thinking About Starting a Family While Living with Multiple Sclerosis
- 6 Common Myths: Multiple Sclerosis & Pregnancy
- What To Expect: MS and pregnancy
“More people than ever before are having babies following diagnosis with MS, but they have a growing list of questions about how to navigate the associated challenges,” said Mary Ray, cofounder and COO of MyHealthTeams. “The MS & Family Planning Resource Center arms MyMSTeam members with information to effectively talk with their doctors about planning for and managing pregnancy.”
MyHealthTeams believes that if you are diagnosed with a chronic condition, it should be easy to find and connect with others like you. MyHealthTeams creates social networks for people living with a chronic health condition. Millions of people have joined one of the company’s 33 highly engaged communities focusing on the following conditions: Crohn’s and colitis, multiple sclerosis, lupus, fibromyalgia, pulmonary hypertension, spondylitis, eczema, myeloma, hyperhidrosis, rheumatoid arthritis, psoriasis, leukemia, lymphoma, irritable bowel syndrome, Parkinson's, Alzheimer's, epilepsy, hemophilia, hidradenitis suppurative, depression, heart disease, type 2 diabetes, osteoporosis, COPD, chronic pain, migraines, food allergies, obesity, HIV, PCOS, endometriosis, breast cancer and autism. MyHealthTeams’ social networks are available in 13 countries.
About EMD Serono
EMD Serono - the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada - is engaged in the discovery, research and development of medicines for patients with difficult to treat diseases. The business is committed to transforming lives by developing and delivering meaningful solutions that help address the therapeutic and support needs of individual patients. Building on a proven legacy and deep expertise in neurology, fertility and endocrinology, EMD Serono is developing potential new oncology and immuno-oncology medicines while continuing to explore potential therapeutic options for diseases such as psoriasis, lupus and MS. Today, the business has approximately 1,300 employees around the country with commercial, clinical and research operations based in the company's home state of Massachusetts.